Barzelloni Ml

Statistics

Publications

Citations

H-Index

Active since

2000

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Barzelloni Ml is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in chemotherapy toxicity management, oncology, and cancer pharmacology.

Publications per year

2000–2000

Publications

Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial.

C Gridelli, Franco Perrone, Ciro Gallo et al. · PubMed · 2000 · 55 citations

Medicine, Oncology, Pharmacology +16

Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.

Cesare Gridelli, L. Frontini, Emiddio Barletta et al. · PubMed · 2000 · 12 citations

Medicine, Oncology, Pharmacology +15

1–2 of 2